3.0.0 3950 2023-01-13T04:50:07Z 2023-01-13T04:50:07Z House H HR 2005-09-29 109 hsif00 Energy and Commerce Committee House Standing hsif14 Health Subcommittee Referred to 2005-10-17T15:47:17Z Referred to 2005-09-29T14:01:10Z 2005-10-17 hsif14 Health Subcommittee 1 House committee actions Referred to the Subcommittee on Health. Committee 2005-09-29 Referred to the House Committee on Energy and Commerce. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2005-09-29 Introduced in House IntroReferral Intro-H 9 Library of Congress 2005-09-29 Introduced in House IntroReferral 1000 9 Library of Congress D000216 Rep. DeLauro, Rosa L. [D-CT-3] ROSA DELAURO D CT 3 N E000172 Rep. Emerson, Jo Ann [R-MO-8] JO EMERSON R MO ANN 8 2005-09-29 True C000714 Rep. Conyers, John, Jr. [D-MI-14] JOHN CONYERS D MI 14 2005-11-01 False M000725 Rep. Miller, George [D-CA-7] GEORGE MILLER D CA 7 2005-11-01 False M001143 Rep. McCollum, Betty [D-MN-4] BETTY MCCOLLUM D MN 4 2005-11-01 False E000287 Rep. Emanuel, Rahm [D-IL-5] Rahm Emanuel D IL 5 2005-11-01 False W000797 Rep. Wasserman Schultz, Debbie [D-FL-20] Debbie Wasserman Schultz D FL 20 2005-11-01 False S000810 Rep. Stark, Fortney Pete [D-CA-13] PETE STARK D CA 13 2005-11-01 False M000404 Rep. McDermott, Jim [D-WA-7] JIM MCDERMOTT D WA 7 2005-11-03 False D000399 Rep. Doggett, Lloyd [D-TX-25] LLOYD DOGGETT D TX 25 2006-06-15 False S000033 Rep. Sanders, Bernard [I-VT-At Large] Bernard Sanders I VT 0 2006-06-28 False Health Administrative procedure Administrative remedies Commerce Communication in medicine Consumer education Department of Health and Human Services Direct mail advertising Drug advertising Drug industry Drugs Fines (Penalties) Government Operations and Politics Health education Labeling Law Physicians Sales promotion Health 00 2005-09-29 Introduced in House 2005-12-01T20:23:33Z Responsibility in Drug Advertising Act of 2005 - Amends the Federal Food, Drug, and Cosmetic Act to prohibit any person from conducting direct-to-consumer advertising of a prescription drug for three years after approval of such drug.

Allows the Secretary of Health and Human Services to: (1) waive such prohibition if such advertising will have an affirmative value to public health; or (2) extend such prohibition for subsequent years if the drug has significant adverse effects.

Provides for civil penalties for violations relating to prescription drug advertisement or promotion. Allows the Secretary to require distribution of corrective information to notify the public and medical community of the violation.

Allows the Secretary to: (1) require information to be included in the labeling of a drug if such information is necessary to ensure the safe and effective use of the drug; and (2) require the manufacturer of a drug to notify the public and the medical community of the labeling change. Deems a drug to be misbranded if such labeling or notification requirements are not met.

Requires the Secretary to conduct an education campaign to increase public awareness of risks that may outweigh the benefits of using a particular drug, whether such risks are known at the time of the approval of the drug or become known later.

]]> Responsibility in Drug Advertising Act of 2005 Display Title Responsibility in Drug Advertising Act of 2005 Official Title as Introduced To amend the Federal Food, Drug, and Cosmetic Act with respect to drug advertising, and for other purposes. Introduced in House IH Short Titles as Introduced Responsibility in Drug Advertising Act of 2005 Introduced in House 2005-09-29T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-109hr3950ih/xml/BILLS-109hr3950ih.xml 2005-10-17 Referred to the Subcommittee on Health. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.